Literature DB >> 660547

Hepatic uptake of propranolol.

J H Anderson, R C Anderson, L S Iben.   

Abstract

Isolated rat livers were perfused with propranolol and other drugs in a simplified recirculation system without plasma proteins or erythrocytes. The propranolol levels in the reservoir declined biphasically. The first phase was rapid and almost flow-limited despite use of high perfusion flow rates. This rapid uptake generated liver/perfusate ratios greater than 25 and was not significantly diminished by lowering the temperature or removing oxygen from the system. It appeared to reflect one or more physical binding processes. Autoradiography showed high concentrations of propranolol in the periportal zones of the liver lobule. The second, slower phase of uptake was associated with metabolism of propranolol to other compounds and was temperature, oxygen and concentration dependent. A number of drugs inhibited the slow phase but had little effect on the rapid uptake phase. Several of these drugs were able to displace small amounts of propranolol from the liver.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 660547

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

3.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

Review 4.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 5.  The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver.

Authors:  D K Meijer; P Van der Sluijs
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

6.  A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

7.  Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.

Authors:  R H Smallwood; D J Morgan; G W Mihaly; D B Jones; R A Smallwood
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

8.  Labetalol steady-state pharmacokinetics in hypertensive patients.

Authors:  J J McNeil; A E Anderson; W J Louis; K Raymond
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

9.  Ethanol-induced inhibition of hepatic uptake of propranolol in perfused rat liver and in man.

Authors:  P Dorian; E M Sellers; H L Kaplan; G Carruthers; C Hamilton; V Khouw
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.